Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


23rd Annual International Light Scattering Colloquium

22 Oct 2012 - 23 Oct 2012 - Santa Barbara, CA, USA



Bookmark and Share


Wyatt Technology is pleased to announce that it is hosting its 23rd Annual International Light Scattering Colloquium (ILSC). At this year’s ILSC, Wyatt plans to celebrate its 30th anniversary with a series of presentations from industry leaders across a wide range of application areas.

Featured sessions include:

• Dr. Adrian Apetri, Crucell “Life in a Pharmaceutical Company Before and After Light Scattering"
• Dr. Tapan Das, Pfizer Inc. "Predicting Aggregation Trend in Protein Therapeutics: Role of Biophysical Methods"
• Dr. Stefan Fischer, F. Hoffman-La Roche Ltd. “Challenges in the Development of Protein Formulations”
• Professor Stephen Harding, University of Nottingham "MALS - A Success Story in Glycopolymer Research"
• Professor Axel Mueller, University of Bayreuth “Self-Organized Multicompartment Nanostructures From New Triblock Terpolymers"
• Professor Andre Nel, University of California Los Angeles "Use of Nanomaterial Libraries and Their Characterization to Understand the Potential Environmental Impact of This Technology"
• Professor Christopher Roberts, University of Delaware "Probing Protein Aggregation Mechanisms and Revisiting Protein-Protein Interactions from 'Low' to 'High' Concentrations"
• Dr. Peter Schuck, National Institutes of Health “Protein Refractive Index Increments and the Structure and Function of Gamma Crystallin”
For more information or to register, please contact Lindsey East at marketing@wyatt.com or call +1 805 681 9009 ext 210.

Further information
Scientific News
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Vaccine Strategy Targets Multiple Influenza Viruses
Scientists have identified vaccine-induced antibodies that can neutralize strains of influenza virus that infect humans.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
'Poison Pill' Fed to Deadly Virus
Researchers have created a genetic modification within a virus (with funny name), rendering it unable to replicate, mutate or cause illness.
World First Alzheimer's Vaccine Breakthrough
Researchers have made a breakthrough discovery towards an effective vaccine for Alzheimer's by targeting associated proteins.
Immunotherapy Drug Combo Targets Cancer
Mayo Clinic researchers identify potential immunotherapy drug combination that shows therapeutic effects against advanced and metastatic cancers.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!